VASOXYL Drug Patent Profile
✉ Email this page to a colleague
When do Vasoxyl patents expire, and when can generic versions of Vasoxyl launch?
Vasoxyl is a drug marketed by Glaxosmithkline and is included in one NDA.
The generic ingredient in VASOXYL is methoxamine hydrochloride. Additional details are available on the methoxamine hydrochloride profile page.
Summary for VASOXYL
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 31 |
Patent Applications: | 2,010 |
Formulation / Manufacturing: | see details |
DailyMed Link: | VASOXYL at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for VASOXYL
US Patents and Regulatory Information for VASOXYL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Glaxosmithkline | VASOXYL | methoxamine hydrochloride | INJECTABLE;INJECTION | 006772-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Glaxosmithkline | VASOXYL | methoxamine hydrochloride | INJECTABLE;INJECTION | 006772-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |